5 Results for "

CIII (apo-CIII) mRNA

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "CIII (apo-CIII) mRNA" in MCE Product Catalog:

Cat. No.: HY-145727A
CAS No.: 1573402-50-2
Purity:  98.51%
Synonyms: ISIS 304801 sodium
Target:  

Apolipoprotein

Research Areas:  

Endocrinology

Volanesorsen (ISIS 304801) sodium is an antisense oligonucleotide inhibitor of apolipoprotein CIII (apo-CIII) mRNA that reduces triglyceride levels and improves insulin resistance. Volanesorsen sodium is being studied in the treatment of hypertriglyceridemia, familial chylosiderosis syndrome, and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-145727
CAS No.: 915430-78-3
Purity:  97.97%
Synonyms: ISIS 304801
Target:  

Apolipoprotein

Research Areas:  

Endocrinology

Volanesorsen (ISIS 304801) is an antisense oligonucleotide inhibitor of apolipoprotein CIII (apo-CIII) mRNA that reduces triglyceride levels and improves insulin resistance. Volanesorsen is being studied in the treatment of hypertriglyceridemia, familial chylosiderosis syndrome, and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-153491
CAS No.: 2097587-83-0
Synonyms: ISIS 678354; IONIS-APOCIII-LRx; AKCEA-APOCIII-LRx
Target:  

Apolipoprotein

Research Areas:  

Cardiovascular Disease

Olezarsen (ISIS 678354;IONIS-APOCIII-LRx) is a GalNAc-modified antisense oligonucleotide. Olezarsen binds to APOC3 mRNA and induces its degradation via ribonuclease H1-mediated sense strand cleavage, thereby reducing hepatic apolipoprotein C-III (apoC-III) synthesis. Olezarsen reduces plasma triglyceride, apolipoprotein B and non-high-density lipoprotein cholesterol levels. Olezarsen is applicable to research related to familial chylomicronemia syndrome, hypertriglyceridemia and atherosclerotic cardiovascular disease .
loading...
    loading...
Cat. No.: HY-145727C
Synonyms: ISIS 304801 scramble negative control
Target:  

Apolipoprotein

Research Areas:  

Endocrinology

Volanesorsen scramble negative control is a negative control for volanesorsen (HY-145727) with the sequence: CAUGUTCUTCUGCATGUCAU. Volanesorsen (ISIS 304801) is an antisense oligonucleotide inhibitor of apolipoprotein CIII (apo-CIII) mRNA that can lower triglyceride levels and improve insulin resistance .
loading...
    loading...
Cat. No.: HY-153491A
CAS No.: 2298451-31-5
Purity:  91.44%
Synonyms: ISIS 678354 sodium; IONIS-APOCIII-LRx sodium; AKCEA-APOCIII-LRx sodium
Target:  

Apolipoprotein

Research Areas:  

Cardiovascular Disease

Olezarsen (ISIS 678354;IONIS-APOCIII-LRx) sodium is a GalNAc-modified antisense oligonucleotide. Olezarsen sodium binds to APOC3 mRNA and induces its degradation via ribonuclease H1-mediated sense strand cleavage, thereby reducing hepatic apolipoprotein C-III (apoC-III) synthesis. Olezarsen sodium reduces plasma triglyceride, apolipoprotein B and non-high-density lipoprotein cholesterol levels. Olezarsen sodium is applicable to research related to familial chylomicronemia syndrome, hypertriglyceridemia and atherosclerotic cardiovascular disease .
loading...
    loading...